Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PROTAC degraders as chemical probes for studying target biology and target validation
Václav Nêmec, Martin P. Schwalm, Susanne Müller, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 18, pp. 7971-7993
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes
Ingo V. Hartung, Joachim Rudolph, Mary M. Mader, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9297-9312
Open Access | Times Cited: 56
Tracking the PROTAC degradation pathway in living cells highlights the importance of ternary complex measurement for PROTAC optimization
Martin P. Schwalm, Andreas Krämer, Anja Dölle, et al.
Cell chemical biology (2023) Vol. 30, Iss. 7, pp. 753-765.e8
Open Access | Times Cited: 46
Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation
Martin P. Schwalm, Amelie Menge, Lewis Elson, et al.
ACS Chemical Biology (2025) Vol. 20, Iss. 1, pp. 94-104
Open Access | Times Cited: 2
Small-molecule probes from bench to bedside: advancing molecular analysis of drug–target interactions toward precision medicine
Sijun Pan, Aixiang Ding, Yisi Li, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 16, pp. 5706-5743
Closed Access | Times Cited: 30
Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies
Xiaopeng Peng, Zhihao Hu, Limei Zeng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 2, pp. 533-578
Open Access | Times Cited: 25
Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research
Xiang Li, Qian Liu, Xin Xie, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1700-1711
Closed Access | Times Cited: 23
Leveraging aptamers for targeted protein degradation
Zhihao Yang, Qiuxiang Pang, Jun Zhou, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 11, pp. 776-785
Closed Access | Times Cited: 23
The impact of E3 ligase choice on PROTAC effectiveness in protein kinase degradation
Tomasz Sobierajski, Joanna Małolepsza, Marta Pichlak, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104032-104032
Open Access | Times Cited: 9
Expanding the ligand spaces for E3 ligases for the design of protein degraders
Rahman Shah Zaib Saleem, Martin P. Schwalm, Stefan Knapp
Bioorganic & Medicinal Chemistry (2024) Vol. 105, pp. 117718-117718
Open Access | Times Cited: 8
Luciferase- and HaloTag-based reporter assays to measure small-molecule-induced degradation pathway in living cells
Martin P. Schwalm, Krishna Saxena, Susanne Müller, et al.
Nature Protocols (2024) Vol. 19, Iss. 8, pp. 2317-2357
Closed Access | Times Cited: 8
Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer
Jinmei Jin, Yaping Wu, Zeng Zhao, et al.
JCI Insight (2022) Vol. 7, Iss. 22
Open Access | Times Cited: 29
How many kinases are druggable? A review of our current understanding
Brian Anderson, Peter Rosston, Han Wee Ong, et al.
Biochemical Journal (2023) Vol. 480, Iss. 16, pp. 1331-1363
Open Access | Times Cited: 21
The most common linkers in bioactive molecules and their bioisosteric replacement network
Peter Ertl, Eva Altmann, Sophie Racine
Bioorganic & Medicinal Chemistry (2023) Vol. 81, pp. 117194-117194
Closed Access | Times Cited: 19
Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506‐Binding Protein 51 (FKBP51)
Thomas Geiger, Michael Walz, Christian Meyners, et al.
Angewandte Chemie International Edition (2023) Vol. 63, Iss. 3
Open Access | Times Cited: 17
Revolutionizing Drug Targeting Strategies: Integrating Artificial Intelligence and Structure-Based Methods in PROTAC Development
Mohd Danishuddin, Mohammad Sarwar Jamal, Kyoung Seob Song, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1649-1649
Open Access | Times Cited: 17
Antibody-Proteolysis Targeting Chimera Conjugate Enables Selective Degradation of Receptor-Interacting Serine/Threonine-Protein Kinase 2 in HER2+ Cell Lines
Karina Chan, Preethi S. Sathyamurthi, Markus A. Queisser, et al.
Bioconjugate Chemistry (2023) Vol. 34, Iss. 11, pp. 2049-2054
Open Access | Times Cited: 14
Pharmacological inhibition of HDAC6 suppresses NLRP3 inflammasome-mediated IL-1β release
Judith Bockstiegel, Silas Wurnig, Jonas Engelhardt, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115693-115693
Closed Access | Times Cited: 13
Potential of the nanoplatform and PROTAC interface to achieve targeted protein degradation through the Ubiquitin–Proteasome system
Hanshu Xie, Chao Zhang
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116168-116168
Closed Access | Times Cited: 5
Application of PROTACs in target identification and validation
Yang Liu, Jing Liang, Rui Zhu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 5
Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery
Rocío Marisol Espinoza-Chávez, Alessandra Salerno, Anastasia Liuzzi, et al.
ACS Bio & Med Chem Au (2022) Vol. 3, Iss. 1, pp. 32-45
Open Access | Times Cited: 22
Single amino acid–based PROTACs trigger degradation of the oncogenic kinase BCR–ABL in chronic myeloid leukemia (CML)
Jianchao Zhang, Caibing Ma, Yongjun Yu, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 8, pp. 104994-104994
Open Access | Times Cited: 12
Auto-RapTAC: A Versatile and Sustainable Platform for the Automated Rapid Synthesis and Evaluation of PROTAC
Jiexuan Chen, Mingfei Wu, Jun Mo, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Workflow for E3 Ligase Ligand Validation for PROTAC Development
Nebojša Miletić, Janik Weckesser, Thorsten Mosler, et al.
ACS Chemical Biology (2025)
Open Access
Predicting PROTAC-targeted Degradation and Designing Androgen Receptor Degraders with AiPROTAC
Li Zhang, Renhong Sun, Xia Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Application of Mass Spectrometry for the Advancement of PROTACs
Hao Yin, Baoshuang Zhang, Ruibing Chen
Journal of Pharmaceutical and Biomedical Analysis (2025), pp. 116829-116829
Closed Access
Page 1 - Next Page

Scroll to top